Provectus Biopharmaceuticals, Inc.

Common Stock SEC Reporting - Current
Verified Company Profile 10/18/2016
Contact Info
  • 7327 Oak Ridge Hwy.
  • Knoxville, TN 37931

Business Description

Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Sep 30, 2016 10-Q
CIK 0000315545
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 2834 - Pharmaceutical preparations
Business Status Development Stage Company a/o
Incorporated In: DE, USA
Year of Inc. 2002
Employees 4 a/o Jan 06, 2014
Company Officers/Contacts
Peter Culpepper CEO, COO
Timothy C. Scott, Ph.D. President
John R. Glass CFO
Eric Wachter, Ph.D. CTO
Seth Orlow Advisory Director
Craig Eagle Advisory Director
Paul M. Goldfarb Advisory Director
Bob Miglani Advisory Director
David Darst Advisory Director
Doug Ulman Advisory Director
Marlon Nurse, D.M. IR, SVP, Inv. Rel.
Company Directors
Alfred E. Smith, IV
Jan E. Koe
Eric Wachter, Ph.D.
Kelly McMasters M.D. Ph.D.
Company Notes
  • Formerly=Provectus Pharmaceutical, Inc. until 1-2014
  • Formerly=Zamage Digital Imaging, Inc. until 4-02
  • Note=4-1-02 State of Incorporation Colorado changed to Nevada
  • Note=12-31-04 company is in the development stage
  • Formerly=SPM Group, Inc. until 11-01
Service Providers
Accounting/Auditing Firm
Marcum LLP
750 Third Ave
11th Floor
New York, NY, 10017
United States

330 North Wabash
Suite 3200
Chicago, IL, 60611
United States

Legal Counsel
Not Available
Investor Relations Firm
Porter, LeVay & Rose
7 Penn Plaza
Suite 810
New York, NY, 10001
United States

PVCT Security Details Other Company Securities
Share Structure
Market Value1 $3,243,808 a/o Dec 08, 2016
Authorized Shares 400,000,000 a/o Oct 14, 2016
Outstanding Shares 243,895,352 a/o Oct 14, 2016
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float 75,807,312 a/o Jun 30, 2016
Par Value 0.001
Shareholders of Record 982 a/o Mar 30, 2016
Short Selling Data
Short Interest 3,497,687 (-3.88%)
Nov 15, 2016
Significant Failures to Deliver No

1Market Value calculated only for respective security